The antiemetic interaction of Delta9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrew.
The antiemetic interaction of Delta9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrew.
复制标题
DOI:
10.1016/j.pbb.2008.08.008
复制
发表时间:
2009-01
影响因子:
3.6
通讯作者:
Darmani, Nissar A.
中科院分区:
文献类型:
--
作者:
Wang, Yaozhi;Ray, Andrew P.;McClanahan, Bryan A.;Darmani, Nissar A.
5-HT3 receptor antagonists (e.g. tropisetron) combined with dexamethasone are effective for the acute phase of cisplatin (CIS)-induced emesis. This study determined the possible additive or synergistic antiemetic efficacy of Δ9-THC when combined with tropisetron or dexamethasone (DEX). Δ9-THC (0 – 10 mg/kg i.p.) was injected in combination with tropisetron (0 – 5 mg/kg i.p.) or dexamethasone (0 – 20 mg/kg i.p.) prior to CIS (20 mg/kg i.p.) in the least shrew, and the induced emesis was recorded for 60 minutes. CIS-induced vomiting was dose-dependently and significantly attenuated by individual administration of Δ9-THC (59–97% reductions) and tropisetron (79–100% attenuation), but not dexamethasone (26–40%), although a trend (p < .1) towards reduced vomiting frequency following DEX was noted. Low doses of Δ9-THC (0.25 or 0.5 mg/kg) when combined with low doses of tropisetron (0.025, 0.1, or 0.25 mg/kg) were more efficacious in reducing emesis frequency than when given individually, but Δ9-THC had no antiemetic interactions with DEX. However, no tested combination provided a significantly greater effect on the number of animals vomiting than their individually-administered counterparts. The modest interaction of Δ9-THC with tropisetron suggests they activate overlapping antiemetic mechanisms, while the lack of interaction with dexamethasone needs further clarification.
登录
查看更多内容
DOI:
10.1016/0277-5379(83)90418-2
发表时间:
1983-01-01
期刊:
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY
影响因子:
--
作者:
COATES, A;ABRAHAM, S;TATTERSALL, MHN
通讯作者:
TATTERSALL, MHN
影响因子:
3.4
作者:
Cross-Mellor, Shelley K.;Ossenkopp, Klaus-Peter;Parker, Linda A.
通讯作者:
Parker, Linda A.
DOI:
10.1016/s0306-3623(98)00102-5
发表时间:
1998-11-01
期刊:
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM
影响因子:
--
作者:
Fukunaka, N;Sagae, S;Minami, M
通讯作者:
Minami, M
影响因子:
2.9
作者:
GARB, S
通讯作者:
GARB, S
影响因子:
5
作者:
Darmani, NA;Johnson, JC
通讯作者:
Johnson, JC